Home LiteratureArticle Details
PMID: 17875987 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.

Tazawa H, Tsuchiya N, Izumiya M, Nakagama H

Abstract

Accumulating evidence suggests a role for microRNAs in human carcinogenesis as novel types of tumor suppressors or oncogenes. However, their precise biological role remains largely elusive. In the present study, we aimed to identify microRNA species involved in the regulation of cell proliferation. Using quantitative RT-PCR analysis, we demonstrated that miR-34a was highly up-regulated in a human colon cancer cell line, HCT 116, treated with a DNA-damaging agent, adriamycin. Transient introduction of miR-34a into two human colon cancer cell lines, HCT 116 and RKO, caused complete suppression of cell proliferation and induced senescence-like phenotypes. Moreover, miR-34a also suppressed in vivo growth of HCT 116 and RKO cells in tumors in mice when complexed and administered with atelocollagen for drug delivery. Gene-expression microarray and immunoblot analyses revealed down-regulation of the E2F pathway by miR-34a introduction. Up-regulation of the p53 pathway was also observed. Furthermore, 9 of 25 human colon cancers (36%) showed decreased expression of miR-34a compared with counterpart normal tissues. Our results provide evidence that miR-34a functions as a potent suppressor of cell proliferation through modulation of the E2F signaling pathway. Abrogation of miR-34a function could contribute to aberrant cell proliferation, leading to colon cancer development.

MeSH Terms
Animals Cell Line, Tumor Cell Proliferation Cellular Senescence Collagen/chemistry,metabolism Doxorubicin/pharmacology E2F Transcription Factors/chemistry,genetics Gene Expression Regulation, Neoplastic Humans Mice MicroRNAs/metabolism,physiology Neoplasm Transplantation Phenotype Tumor Suppressor Protein p53/metabolism
Chemicals
E2F Transcription Factors MIRN34 microRNA, human MicroRNAs TP53 protein, human Tumor Suppressor Protein p53 Doxorubicin Collagen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tazawa Hiroshi
Biochemistry Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Tsuchiya Naoto
Izumiya Masashi
Nakagama Hitoshi
References (37)
37 references, click to expand
  1. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
    Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12177-82 PMID: 16091473
  2. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
    Cancer Res. 2007 Oct 1;67(19):9568-76 PMID: 17909068
  3. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
    N Engl J Med. 2005 Oct 27;353(17):1793-801 PMID: 16251535
  4. Involvement of E2F transcription factor family in cancer.
    Eur J Cancer. 2005 Nov;41(16):2403-14 PMID: 16213134
  5. A microRNA expression signature of human solid tumors defines cancer gene targets.
    Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 PMID: 16461460
  6. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
    Nat Rev Cancer. 2006 Feb;6(2):107-16 PMID: 16491070
  7. MicroRNA signatures in human cancers.
    Nat Rev Cancer. 2006 Nov;6(11):857-66 PMID: 17060945
  8. The HBP1 transcriptional repressor participates in RAS-induced premature senescence.
    Mol Cell Biol. 2006 Nov;26(22):8252-66 PMID: 16966377
  9. MicroRNA responses to cellular stress.
    Cancer Res. 2006 Nov 15;66(22):10843-8 PMID: 17108120
  10. Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation.
    J Biol Chem. 2006 Nov 24;281(47):36124-31 PMID: 17008321
  11. Cancer research with non-coding RNA.
    Cancer Sci. 2006 Dec;97(12):1285-90 PMID: 17052264
  12. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop.
    Mol Cell Biol. 2007 Jan;27(1):65-78 PMID: 17167174
  13. Cancer epigenomics: DNA methylomes and histone-modification maps.
    Nat Rev Genet. 2007 Apr;8(4):286-98 PMID: 17339880
  14. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure.
    Mutat Res. 2007 Jun 1;619(1-2):30-7 PMID: 17343880
  15. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Mol Cell. 2007 Jun 8;26(5):731-43 PMID: 17540598
  16. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Mol Cell. 2007 Jun 8;26(5):745-52 PMID: 17540599
  17. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  18. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Oncogene. 2007 Jul 26;26(34):5017-22 PMID: 17297439
  19. Myc requires distinct E2F activities to induce S phase and apoptosis.
    Mol Cell. 2001 Jul;8(1):105-13 PMID: 11511364
  20. Detection and isolation of minisatellite Pc-1 binding proteins.
    Biochim Biophys Acta. 2001 Oct 3;1528(2-3):152-8 PMID: 11687302
  21. The E2F1-3 transcription factors are essential for cellular proliferation.
    Nature. 2001 Nov 22;414(6862):457-62 PMID: 11719808
  22. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    Methods. 2001 Dec;25(4):402-8 PMID: 11846609
  23. A micrococcal nuclease homologue in RNAi effector complexes.
    Nature. 2003 Sep 25;425(6956):411-4 PMID: 14508492
  24. MicroRNAs: genomics, biogenesis, mechanism, and function.
    Cell. 2004 Jan 23;116(2):281-97 PMID: 14744438
  25. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
    Cancer Res. 2004 May 15;64(10):3365-70 PMID: 15150085
  26. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
    Nucleic Acids Res. 2004;32(13):e109 PMID: 15272050
  27. Random-effects models for longitudinal data.
    Biometrics. 1982 Dec;38(4):963-74 PMID: 7168798
  28. p53 mutations in colorectal cancer.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9 PMID: 1699228
  29. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
    Genes Dev. 1994 Jul 1;8(13):1514-25 PMID: 7958836
  30. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
    Cancer Res. 1997 Jul 1;57(13):2765-80 PMID: 9205089
  31. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
    Science. 1998 Nov 20;282(5393):1497-501 PMID: 9822382
  32. Genetic instabilities in human cancers.
    Nature. 1998 Dec 17;396(6712):643-9 PMID: 9872311
  33. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet.
    Nat Med. 1999 Jun;5(6):707-10 PMID: 10371512
  34. Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
    J Clin Invest. 1999 Aug;104(3):263-9 PMID: 10430607
  35. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
    J Cell Biol. 2005 Feb 14;168(4):553-60 PMID: 15716376
  36. MicroRNA expression profiles classify human cancers.
    Nature. 2005 Jun 9;435(7043):834-8 PMID: 15944708
  37. MicroRNA functions in animal development and human disease.
    Development. 2005 Nov;132(21):4653-62 PMID: 16224045
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2007-09-25
Epub
2007-00-17
Pages
15472-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2000550
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]